SIGN UP
LOG IN
F
01652
Fusen Pharmaceutical
0.39
0.09+30.00%Closed16:08 05/23 HKT
OPEN/PREV CLOSE0.315/0.300
TODAY RANGE0.315-0.450
VOL4.31M
MARKET CAP288.33M
52 WEEK RANGE0.235-1.200
AVG VOL (3M)332.54K
% TURNOVER0.58%
TURNOVER1.60M
P/E (TTM)-1.414
% RANGE45.00%
EPS(TTM)-0.276
P/E(FORWARD)--
P/B0.722
BVPS0.540
DIVIDEND--
P/S0.475
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP288.33M
SHARES OUTSTANDING739.30M
NEXT EARNINGS--
FREE FLOAT739.30M
LOT SIZE1000
EX-DIV DATE--
News
Press Releases
Financial Reports
Profile
Simply Wall St·05/08 22:38
Improved Revenues Required Before Fusen Pharmaceutical Company Limited (HKG:1652) Stock's 27% Jump Looks Justified
Simply Wall St·04/02 22:09
Fusen Pharmaceutical Full Year 2024 Earnings: CN¥0.26 loss per share (vs CN¥0.048 loss in FY 2023)
Simply Wall St·02/12 22:06
Benign Growth For Fusen Pharmaceutical Company Limited (HKG:1652) Underpins Stock's 42% Plummet
Simply Wall St·01/22 03:43
Fusen Pharmaceutical Insiders Lose Out As Stock Sinks To HK$0.60
Simply Wall St·12/18/2024 01:31
There's Reason For Concern Over Fusen Pharmaceutical Company Limited's (HKG:1652) Price
Reuters·08/29/2024 14:59
FUSEN PHARMACEUTICAL H1 GROSS PROFIT RMB 105.9 MILLION
Same Industry
Name/Symbol
Change%
Price
Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.